Source: Future Medicinal Chemistry. Unidade: FCF
Subjects: LIGANTES, NEOPLASIAS
ABNT
GIAROLLA, Jeanine et al. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry, v. 17, n. 5, p. 607–627, 2025Tradução . . Disponível em: https://dx.doi.org/10.1080/17568919.2025.2463868. Acesso em: 28 abr. 2025.APA
Giarolla, J., Holdaway, K. A., Nazari, M., Aiad, L., Sarkar, B., & Georg, G. I. (2025). Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception. Future Medicinal Chemistry, 17( 5), 607–627. doi:10.1080/17568919.2025.2463868NLM
Giarolla J, Holdaway KA, Nazari M, Aiad L, Sarkar B, Georg GI. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception [Internet]. Future Medicinal Chemistry. 2025 ; 17( 5): 607–627.[citado 2025 abr. 28 ] Available from: https://dx.doi.org/10.1080/17568919.2025.2463868Vancouver
Giarolla J, Holdaway KA, Nazari M, Aiad L, Sarkar B, Georg GI. Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception [Internet]. Future Medicinal Chemistry. 2025 ; 17( 5): 607–627.[citado 2025 abr. 28 ] Available from: https://dx.doi.org/10.1080/17568919.2025.2463868